Analytical validation of hepatitis B core‐related antigen (HBcrAg) using dried blood spots (DBS)

Limited access to nucleic acid testing (NAT) to quantify HBV DNA levels, an essential tool to determine anti‐HBV treatment eligibility, represents a significant barrier to scale up HBV diagnostic services in resource‐limited countries. Hepatitis B core‐related antigen (HBcrAg) has the potential to b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Viral Hepat
Autors principals: Shimakawa, Yusuke, Vernoux, Laura, Gabassi, Audrey, Mercier‐Delarue, Séverine, Vincent, Jeanne Perpétue, Simon, François, Maylin, Sarah
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247985/
https://ncbi.nlm.nih.gov/pubmed/33599049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.13489
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars